Home Sable Bio

Sable Bio

In operation
Seed Round Financing
Developer of Artificial Intelligence Enhanced Platforms
Basic
Enterprise Profile

Basic Information

Sable Bio is developing a unique AI-enhanced platform designed to provide predictive safety insights for pharmaceutical companies, reducing the risk of clinical trial failures. Their innovative approach involves extracting proprietary signals from structured and unstructured data sources, leveraging large language models, causal inference techniques, and extensive domain knowledge.
Sable Limited
London,England,United Kingdom
less than 15 people
January 01, 2023
--

Enterprise Profile

Industrial Sector
New Drug Development Information Technology Vendors CXO (Pharmaceutical Outsourcing Organization)
Technology
Artificial Intelligence
Application Scenarios
Innovative Drugs